pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 1·1 min read
save

Amgen files update to Tavneos label as FDA escalates push to withdraw

Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA. The company filed a supplement on Wednesday that would add more information to the warning ...

May 1, 2026·read at Endpoints ↗

May 1, 2026 09:02 AM EDTUpdated 03:04 PM FDA+ Am­gen files up­date to Tavneos la­bel as FDA es­ca­lates push to with­draw Nicole DeFeudis Senior Reporter Am­gen has tak­en steps to up­date its Tavneos la­bel amid an on­go­ing bat­tle with the FDA. The com­pa­ny filed a sup­ple­ment … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
81 words · retrieved May 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN2
drugs
avacopan4

related stories

  • 2d agoTavneos no longer available for new patients in UK as Amgen awaits FDA hearingBioSpace
  • Aug 14Pressure piles on Amgen after EU pulls Tavneos, flags 'serious breaches' in pivotal studyBioSpace
  • Aug 13'Incorrect and misleading' data prompted decision to pull Tavneos in EuropeEndpoints
  • Aug 3Amgen hit with cybersecurity breach, patient data affectedBioSpace
  • Jul 29Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, moreBioSpace